PDX Model CROs: Patient-Derived Xenograft Studies

7 contract research organizations in our directory list PDX Models as a capability, across 4 countries. 0 report GLP capability and 0 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.

7 CROs 4 countries

About PDX Models

Patient-derived xenograft (PDX) models are created by implanting tumor tissue from patients directly into immunodeficient mice. Because they are passaged as tissue rather than grown as cell lines, they keep more of the original tumor histology, heterogeneity and genetics, which makes them a better predictor of clinical response than many cell-line xenografts.

Most CROs offering PDX work hold banks of characterized models with genomic, transcriptomic and treatment-history data, so sponsors can choose models carrying a specific mutation or resistance profile. Population-style "mouse clinical trials" test a drug across many models, often with one or a few animals per model, to see which tumor types respond and why.

Two limits are worth planning for. Human stroma is gradually replaced by mouse stroma, and without a functional immune system, immuno-oncology agents need humanized-mouse PDX or syngeneic models instead. Growth rates also vary widely between models, so lead time to study start depends on which ones you choose.

PDX Model CROs: Patient-Derived Xenograft Studies

Showing 7 CROs. Order rotates daily so no lab is permanently listed first.

XenTech

FR

French translational oncology CRO built around patient-derived xenograft models, with drug response and biomarker discovery services.

PDX Models Biomarker Analysis In Vivo Efficacy Oncology Models Mouse

Hera BioLabs

US

Kentucky CRO developing immunodeficient rat and mouse models, offering xenograft efficacy and safety studies in larger rodent hosts.

PDX Models In Vivo Efficacy Oncology Models Toxicology Xenograft Models Mouse Rat

Certis Oncology Solutions

US

San Diego oncology CRO offering patient-derived and orthotopic tumor models for in vivo efficacy and translational studies.

PDX Models In Vivo Efficacy Oncology Models Xenograft Models Mouse

GemPharmatech

CN

Chinese provider of genetically engineered mouse models with in vivo pharmacology services across oncology, immunology and metabolic disease.

PDX Models In Vivo Efficacy Metabolic Disease Models Oncology Models Mouse

Shanghai LIDE Biotech

CN

Shanghai oncology CRO with patient-derived xenograft and other tumor models for efficacy studies.

PDX Models In Vivo Efficacy Oncology Models Mouse

The Jackson Laboratory (JAX In Vivo Services)

US

Nonprofit mouse genetics institute offering contract in vivo pharmacology using its own strains and humanized and PDX models across oncology, neuroscience, metabolism and immunology.

PDX Models In Vivo Efficacy Metabolic Disease Models Neurodegenerative Models Oncology Models Mouse

Questions to ask when choosing a PDX Models CRO

  • How many models do you hold for our indication, and what molecular and treatment-history data come with each?
  • At what passage are models used, and how do you confirm they still match the original tumor?
  • What are the take rate and typical time to enrollment for the models we are interested in?
  • Do you offer humanized-mouse PDX for immuno-oncology work?
  • Can you run a mouse clinical trial design, and how do you analyze response across models?